A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]
A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]
Recruiting · NCT07331155 · Registry updated 2026-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)] | Advanced Solid Tumour | Recruiting | Phase 2 | 2026-05-18 | NCT07331155 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanjing Leads Biolabs Co.,Ltd | 13 |
| Peking University Cancer Hospital & Institute | 189 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anyang Tumor Hospital | Anyang | China | 9 |
| Beijing Cancer Hospital | Beijing | China | 208 |
| Henan Cancer Hospital | Zhengzhou | China | 76 |
| Shandong Cancer Hospital | Jinan | China | 86 |
| Suining Central Hospital | Suining | China | 5 |
| The First Affiliated Hospital of Henan University of Science & Technology | Luoyang | China | 6 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 6 |